The Link Between Obesity and CRM Conditions

Key Takeaways

Obesity management is crucial in patient-centered care for cardiometabolic conditions, affecting disease progression and treatment outcomes.
Challenges in managing CRM conditions in obese patients include medication dosing, comorbidities, and lifestyle modification adherence.
Addressing these challenges requires personalized treatment plans, multidisciplinary approaches, and patient education.
Effective weight management strategies include behavioral interventions, pharmacotherapy, and bariatric surgery, leading to improvements in CRM conditions.

Experts in the field of cardiometabolic risk management analyze the link between obesity and cardiometabolic conditions, outlining challenges and proposing potential solutions.

EP: 1.The Impact of CRM Diseases in the US: Burden, Prevalence, and Obesity

EP: 2.Strategies for Prevention and Screening of CRM Conditions

Now Viewing

EP: 3.The Link Between Obesity and CRM Conditions

EP: 4.Challenges in Managing Co-Morbid CRM Conditions

EP: 5.Contemporary Guidelines for CRM Conditions

EP: 6.Reasons for Low Adherence to Guidelines for CRM Conditions

EP: 7.Overcoming Barriers to Prescribing First-Line Medications for CRM Conditions

EP: 8.Educational Initiatives to Enhance Guideline Adherence in CRM

EP: 9.Addressing Gaps in CKD, T2D, and CVD Guidelines

EP: 10.Care Coordination for High-Risk CRM Patients

EP: 11.Takeaways from the UH CINEMA Program

EP: 12.Exploring the Kidney-CHAMP Study

EP: 13.Insights from the COORDINATE-Diabetes Trial

EP: 14.Coordinating Initiatives to Enhance CRM Care

EP: 15.Implementing CRM Learnings and Utilization of Telehealth

Video content above is prompted by the following:

How does the management of obesity factor into the patient centered care for patients with these CRM conditions?
Are there any specific challenges in managing CRM conditions in patients with obesity? How can these challenges be addressed?
What specific strategies have you implemented to both prevent and treat the complex disease of obesity?
Can you share any success stories or case studies where weight management interventions have led to improvements in CRM conditions?

This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.